NMR-SPECTROSCOPY OF HUMAN POSTMORTEM CEREBROSPINAL-FLUID - DISTINCTION OF ALZHEIMERS-DISEASE FROM CONTROL USING PATTERN-RECOGNITION AND STATISTICS

被引:50
作者
GHAURI, FYK
NICHOLSON, JK
SWEATMAN, BC
WOOD, J
BEDDELL, CR
LINDON, JC
CAIRNS, NJ
机构
[1] WELLCOME RES LABS, DEPT PHYS SCI, LANGLEY COURT, BECKENHAM BR3 3BS, KENT, ENGLAND
[2] UNIV LONDON, BIRKBECK COLL, DEPT CHEM, LONDON WC1H 0PP, ENGLAND
[3] INST PSYCHIAT, DEPT NEUROPATHOL, LONDON SE5 8AF, ENGLAND
关键词
D O I
10.1002/nbm.1940060210
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
H-1 NMR spectra have been measured at 500 and 600 MHz on 23 human cerebrospinal fluid samples obtained at autopsy from Alzheimer's disease patients and controls. The spectra at 500 MHz were quantified using 42 descriptors based on NMR peak heights and it was shown that differences between the two classes were apparent in the delta2.4-2.9 region. Remeasured at 600 MHz a detailed examination of this chemical shift range identified citrate, aspartate, N-acetyl aspartate, methionine and glutamate in this region of the spectra. Principal components analysis showed that a separation of the two classes was possible and detailed statistics indicated that citrate level was the principal marker. Patient age and the interval between death and autopsy (parameters not closely matched between the two groups) were examined statistically to establish whether these might account for the citrate differences. Although they could possibly account for them to some extent, the relationship between citrate levels and disease state remained significant at p<0.05. The data invite a test of the importance of citrate levels in Alzheimer's disease using samples taken ex vivo.
引用
收藏
页码:163 / 167
页数:5
相关论文
共 23 条
  • [1] BALES JR, 1985, 4TH SOC MAGN RES MED, V2, P1129
  • [2] HIGH-RESOLUTION PROTON NUCLEAR-MAGNETIC-RESONANCE STUDIES OF HUMAN CEREBROSPINAL-FLUID
    BELL, JD
    BROWN, JCC
    SADLER, PJ
    MACLEOD, AF
    SONKSEN, PH
    HUGHES, RD
    WILLIAMS, R
    [J]. CLINICAL SCIENCE, 1987, 72 (05) : 563 - 570
  • [3] INVIVO P-31 NMR PROFILES OF ALZHEIMERS-DISEASE AND MULTIPLE SUBCORTICAL INFARCT DEMENTIA
    BROWN, GG
    LEVINE, SR
    GORELL, JM
    PETTEGREW, JW
    GDOWSKI, JW
    BUERI, JA
    HELPERN, JA
    WELCH, KMA
    [J]. NEUROLOGY, 1989, 39 (11) : 1423 - 1427
  • [4] ACCURACY OF CLINICAL-DIAGNOSIS OF ALZHEIMERS-DISEASE
    BURNS, A
    LUTHERT, P
    LEVY, R
    JACOBY, R
    LANTOS, P
    [J]. BRITISH MEDICAL JOURNAL, 1990, 301 (6759) : 1026 - 1026
  • [5] DAWSON RMC, 1990, DATA BIOCH RES, P411
  • [6] Gartland K P, 1990, NMR Biomed, V3, P166, DOI 10.1002/nbm.1940030404
  • [7] GARTLAND KPR, 1991, MOL PHARMACOL, V39, P629
  • [8] DIAGNOSIS OF ALZHEIMERS-DISEASE
    KHACHATURIAN, ZS
    [J]. ARCHIVES OF NEUROLOGY, 1985, 42 (11) : 1097 - 1104
  • [9] ELEVATION IN RELATIVE LEVELS OF BRAIN MEMBRANE UNSATURATED FATTY-ACIDS IN ALZHEIMERS-DISEASE - HIGH-RESOLUTION PROTON SPECTROSCOPIC STUDIES OF MEMBRANE LIPID EXTRACTS
    KWEE, IL
    NAKADA, T
    ELLIS, WG
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1991, 21 (01) : 49 - 54
  • [10] TETRAHYDROBIOPTERIN METABOLISM IN SENILE DEMENTIA OF ALZHEIMER TYPE
    MORAR, C
    WHITBURN, SB
    BLAIR, JA
    LEEMING, RJ
    WILCOCK, GK
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1983, 46 (06) : 582 - 582